Skip to main content
. 2008 Jan 28;7:21. doi: 10.1186/1475-2875-7-21

Figure 5.

Figure 5

Results with the harm of treatment included. Total costs for children with a high (left) and low (right) estimate of harm of treatment associated with provision of antimalarials and antibiotics. Even with a very conservative estimate of the potential harm of treatment, the HRP2 test maintains an advantage across all prevalences. PT – presumptive treatment